Home > Financial Ratios > HESTER BIOSCIENCES

HESTER BIOSCIENCES
Core EBITDA Growth

    Back to All Ratios
AD     Remove this Ad

HESTER BIOSCIENCES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 1.06-2.23-10.800.5218.74

What is the latest Core EBITDA Growth ratio of HESTER BIOSCIENCES ?

The latest Core EBITDA Growth ratio of HESTER BIOSCIENCES is 1.06 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar20251.06
Mar2024-2.23
Mar2023-10.80
Mar20220.52
Mar202118.74

How is Core EBITDA Growth of HESTER BIOSCIENCES Trending?

Years Core EBITDA Growth % Change
Mar2025 1.06
Positive
Mar2024 -2.23
Negative
Mar2023 -10.8
Negative
Mar2022 0.52
-97.23
Mar2021 18.74 -

Other Financial Ratios of HESTER BIOSCIENCES


Compare Core EBITDA Growth ratio of peers of HESTER BIOSCIENCES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
HESTER BIOSCIENCES ₹1,332.0 Cr 2.4% 7.4% -13.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,062.0 Cr 0.4% 2.6% NA Stock Analytics
DIVIS LABORATORIES ₹164,192.0 Cr -4.5% 0.7% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,129.0 Cr 5% 4.1% 37.2% Stock Analytics
CIPLA ₹108,513.0 Cr -0.5% -3.4% -6.7% Stock Analytics
DR REDDYS LABORATORIES ₹107,250.0 Cr 1.2% 10.2% 4.8% Stock Analytics


HESTER BIOSCIENCES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
HESTER BIOSCIENCES

2.4%

7.4%

-13.6%

SENSEX

-1%

-0.1%

7.9%


You may also like the below Video Courses